A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant

Journal of Endocrinological Investigation

Volumn 29, Issue 4, 2006, Pages 330-336

  Giordano, Mario ^a   Colella, V ^a   Dammacco, A ^a   Torelli, C ^a   Grandaliano, G ^b   Teutonico, A ^b   Depalo, T ^a   Caringella, D A ^a   Di Paolo, S ^b  

^a Pediatric Hospital Giovanni XXIII   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Cyclosporine; Oral glucose tolerance test; Post transplant diabetes; QUICKI HOMA IR; Tacrolimus

Indexed keywords

AZATHIOPRINE; C PEPTIDE; CREATININE; CYCLOSPORIN A; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE CLEARANCE; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; QUANTITATIVE ANALYSIS; SAMPLE SIZE; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

EID: 33745210995     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344104     Document Type: Article

References (35)

1. Viberti G. Diabetes mellitus: a major challenge in transplantation. Transplant Proc 2001, 33 (Suppl 5): 3-7S.
2. Vasco L, Busson M, Bedrossian J, Bitker MO, Hiesse C, Lang P. Diabetes mellitus after renal transplantation: characteristic, outcome and risk factors. Transplantation 1996, 61: 1475-8.
3. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 2001, 15: 89-94.
4. Chilcott JB, Whitby SM, Moore R. Clinical Impact and health economic conseguences of posttransplant Type 2 diabetes mellitus transplantation. Proceedings 2001, 33 (Suppl 5): 32-9S.
5. Hjelmesæth J, Hartmann A, Kofstad J, Stenstrom J, Leivstad J, Fauchald P. Glucose intolerance after renal transplantation depends upon prednisone dose and recipient age. Transplantation 1997, 64: 979-83.
6. Hjelmesæth J, Hartmann A, Kofstad J, Egeland T, Stenstrom, Fauchald P. Tapering off prednisone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant 2001, 16: 829-35.
7. Reisaeter AV, Hartmann A. Risk factors and incidence of posttransplant diabetes mellitus. Transplantation Proceedings 2001, 33 (Suppl. 5): 8S-18S.
8. Davidson J, Wilkinson A, Dantal J, et al. Diabetes after transplantation: 2003 International Consensus Guidelines. Transplantation 2003, 75: SS3-24.
9. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2003, 25: 583-92.
10. Paolillo JA, Boyle GJ, Law YM. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus based immunosuppression. Transplantation 2001, 71: 252-6.
11. Al-Uzri A, Stablein DM, A Cohn. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 2001, 72: 1020-4.
12. Greenspan LC, Gitelman SE, Leung MA, Glidden DV, Mathias RS. Increased incidence in post-transplant diabetes mellitus in children: a case control analysis. Pediatr Nephrol 2003, 17: 1-5.
13. Trompeter R, Filler G, Webb NJ, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2003, 17: 141-9.
14. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334: 374-81.
15. Nijpels G. Determinant for the progression from impaired glucose tolerance to non insulin-dependetn diabetes mellitus. Eur J Clin Invest 1998, 28 (Suppl 2): 8-13.
16. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003, 46: 3-19.
17. Hanefeld M, Koehler C, Henkel E, et al. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intimamedia thickness: the RIAD Study. Risk factors in impaired glucose tolerance for atherosclerosis and diabetes. Diabet Med 2000, 17: 835-40.
18. Larsson H, Berglund G, Lindgarde F, Ahren B. Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia 1998, 41: 1124-5.
19. de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. The 1997 American Diabetes Association criteria versus the 1985 Wordl Health Organization criteria for the 14 diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 1998, 21: 1686-90.
20. Cacciari E, Milani S, Balsamo A, et al. Italian cross sectional growth charts for height, weight and BMI. Eur J Clin Nutr 2002, 56: 171-80.
21. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85: 2402-10.
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9.
23. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004, 144, 1: 47-55.
24. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26 (Suppl 1): S5-20.
25. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000, 23: 295-301.
26. The Expert Committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26: 3160-7.
27. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes. A systematic review of the literature. Diabetes Care 2002, 25: 583-92.
28. Cotellessa M, Pastorino N, Cresta L, et al. Diabetes mellitus after kidney transplantation in pediatric recipients. Pediatr Nephrol 2003, 18: 1315-6.
29. Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired 15 glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 2003, 26: 1333-7.
30. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. Obstet Gynecol Surv 2004, 59: 822-4.
31. Reaven PD, Traustadottir T, Brennan J, Nader PR. Cardiovascular risk factors associated with insulin resistance in children persist into late adolescence. Diabetes Care 2005, 28: 148-50.
32. Aldamiz-Echevarria L, Sanjurjo P, Vallo A, et al. Genetic and metabolic determinants of increased plasma plasminogen activator inhibitor-1 activity in children with renal transplants. Pediatr Nephrol 2003, 18: 749-55.
33. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000, 356: 993-7.
34. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Posttransplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001, 59: 732-7.
35. Henriksen JH, Tronier B, Bulow JB, Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man. Metabolism 1987, 36: 463-8.